Neemat Srour
Neemat Srour, a spring 2020 PharmD graduate, has lived and worked all over the world.
From earning a Master’s degree in France to working as a hospital pharmacist in Saudi Arabia, she has grown an international career with a major goal in mind: one day expanding the profession of pharmacy in Lebanon, her home country.
Note: This story is part of an ongoing series, “Pharmacists on the Front Lines,” which highlights the work of CU pharmacists in the COVID-19 battle. Read the first story here.
Even the most well-stocked hospital in the U.S. is not immune to an all-too-familiar consequence of the COVID-19 pandemic: drug shortages. As the FDA monitors the drug supply chain contributing to the supply disruptions and shortage of drug products, pharmacists in COVID-19 units are using their drug expertise to develop innovative solutions. Read More
Pharmacists are playing a critical role in the response to the coronavirus pandemic. From the halls of hospitals to the counters of community pharmacies, they are caring for patients at every level of the pandemic. Faculty members at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences are no exception. Read More
As the coronavirus pandemic grows, so does the reliance on health care workers around the world. From social media salutes to neighborhood parades, the world is finding innovative ways to applaud the efforts of the medical community on the front line of the fight against COVID-19. Read More
During the coronavirus pandemic, experts at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences can be counted on to answer some of the public’s most pressing questions.
From working to develop a treatment to help COVID-19 patients to speaking about the impact on the U.S. drug supply, our faculty members are in the news. Read More
As scientists around the world scramble against the COVID-19 clock, searching for a vaccine that could stop the viral infection before it happens, a trio of experts on the University of Colorado Anschutz Medical Campus have taken a different tack: overpowering the new mutation after it invades the body. Read More
